MF · holdings as filed 2026-04-30

What's inside AHSAX?

ALGER HEALTH SCIENCES FUND
Holdings
59
positions in the fund
Top 10
36%
of fund assets
Expense ratio
1.17%
net, per year
Fund size
$61M
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
T
TEVATEVA PHARMACEUTICAL-SP ADR
4.65%
2
F
FBRXFORTE BIOSCIENCES INC
4.34%
3
A
ARWRARROWHEAD PHARMACEUTICALS IN
4.10%
4
J
JNJJOHNSON & JOHNSON
3.04%
5
T
TWSTTWIST BIOSCIENCE CORP
2.98%
6
M
MRKMERCK & CO. INC.
2.93%
7
N
NKTRNEKTAR THERAPEUTICS
2.70%
8
R
ROIVROIVANT SCIENCES LTD
2.58%
9
G
GILDGILEAD SCIENCES INC
2.43%
10
S
SYRESPYRE THERAPEUTICS INC
2.36%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
F
FBRXFORTE BIOSCIENCES INC
4.34%
2
A
ARWRARROWHEAD PHARMACEUTICALS IN
4.10%
3
W
WELLWELLTOWER INC
3.28%
4
C
CAHCARDINAL HEALTH INC
3.27%
5
J
JNJJOHNSON & JOHNSON
3.04%
6
T
TWSTTWIST BIOSCIENCE CORP
2.98%
7
M
MRKMERCK & CO. INC.
2.93%
8
N
NKTRNEKTAR THERAPEUTICS
2.70%
9
C
CTVACORTEVA INC
2.59%
10
G
GILDGILEAD SCIENCES INC
2.43%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold AHSAX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.